How many hedge funds invest in Tempus AI?

33 hedge funds invest in Tempus AI, according to the article.

What is Tempus AI's ranking on the list of stocks that could 10X?

Tempus AI ranks 7th on the list of '10 Stocks That Will 10X According to Social Media'.

Should I invest in Tempus AI based on Reddit discussions?

No, you should conduct independent research and consider risks, as social media predictions may not be reliable.

Redditors See 10X Potential in Tempus AI Stock

Tempus AI (NASDAQ:TEM) has been highlighted by Reddit users as a potential 10X stock, ranking 7th on a list of '10 Stocks That Will 10X According to Social Media'. The company runs cancer diagnostic tests and sells data and AI tools to pharma and research institutions, with 33 hedge funds invested.

June 23, 2026

2 min read

Source: Insider Monkey

Key Numbers

hedge fund investors

Discussions on Reddit suggest that Tempus AI (NASDAQ:TEM) could be among the stocks with 10X growth potential. The company, ranked 7th on a list of '10 Stocks That Will 10X According to Social Media', specializes in cancer diagnostic tests and sells the resulting data and AI tools to pharmaceutical companies and research institutions.

Details

According to an article by Insider Monkey, 33 hedge funds hold positions in Tempus AI. The company uses advanced technologies to analyze genomic and clinical data, aiding in the development of personalized cancer treatments.

Context

These predictions come amid growing investor interest in the biotech sector, particularly with the integration of AI in healthcare. However, investors should exercise caution, as 10X growth predictions are based on informal social media opinions.

What It Means for Investors

Despite the optimism, investors should conduct their own research and consider the risks associated with investing in early-stage biotech companies. Relying solely on Reddit discussions as an indicator may be misleading.

Frequently Asked Questions

Tempus AI is a company that runs cancer diagnostic tests and sells the resulting data and AI tools to pharmaceutical companies and research institutions.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.